quiz bu lëkkale ak tegtal · Diggante Niveau

IA ci kaaraange drog ak saytu farmako

Xoolaat rapoor yi ci xew-xew yu baaxul yi, gis siñaal yi ak kodage buñ yamale ci liggéeyu surveillance kaaraange drog ci produit yépp.

Laaj 1 de 8

Luy mébetu farmakovigilans bu njëkk bi?

Xoolaatal laaj bu nekk8 laaj

Sooy def quiz bi, tontu yi ak leeral yi dañuy feeñ.

  1. Luy mébetu farmakovigilans bu njëkk bi?
    • Gis, natt, ak moytu loraange yi ci garab yi ginaaw buñu leen jëfandikoo
    • Jaay garab yu bees ci doktër yi
    • Defar njëgu jaay garab yi
    • Defar emballage pillule
  2. In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
    • Only patients’ handwritten signatures
    • Medication and adverse-event concepts and their relations
    • Only final regulatory decisions
    • Only medicine prices
  3. Lan la jàngat bu jaarul yoon gis ci base de done yiy wane jafe-jafe yi?
    • Seen wuutu ci njëg yi ci digganté garabi màrk yi ak garabi generik yi
    • Ban hopitaal moo joxe rapoor yi gëna bari
    • Ñaari xew-xewu drog ñoo gëna bari luñuy wax ci lim yi
    • Bisu jeexal garab yi
  4. What is VigiBase, according to Uppsala Monitoring Centre?
    • A database of randomized clinical-trial efficacy results only
    • A list of confirmed causal side effects for every medicine
    • A commercial catalogue of approved drug prices
    • The WHO global database of reported adverse events for medicines and vaccines
  5. Lan lañuy jëfandikoo MedDRA ci gasoduk farmakovigilans?
    • Vocabulaire medikaal buñ yamale ngir kode reacsioŋ ak paj
    • Benn màrku emballage farmasi
    • Aplikaasioŋ buy jàppale doktër yi
    • Benn xeetu scanner MRI
  6. Which sequence does UMC describe in its signal-management process?
    • Diagnosis, prescription, dispensing, billing and discharge
    • Detection, validation, prioritisation, assessment and communication
    • Data collection, automatic causality decision, recall and litigation
    • Model training, deployment, billing and marketing
  7. How should a high disproportionality score in a spontaneous-report database be interpreted?
    • As a population incidence rate for all patients
    • As a confirmed causal adverse reaction
    • As a statistical signal for further assessment, not proof that the drug caused the event
    • As proof that no other factor contributed
  8. Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
    • A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
    • A product label, a randomized trial, a treatment response, and a safety committee vote
    • A hospital admission, a known dose, a genetic profile, and a published case report
    • An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter